|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's Range||1.86 - 1.98|
|52 Week Range||0.45 - 5.00|
|PE Ratio (TTM)||N/A|
|Earnings Date||Nov 7, 2017 - Nov 13, 2017|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||4.17|
NEW YORK, NY / ACCESSWIRE / April 20, 2018 / U.S. markets slipped Thursday as tech and consumer staples sectors disappointed investors. The Dow Jones Industrial Average declined 0.34 percent to close at ...
TransEnterix Inc (AMEX:TRXC), a medical equipment company based in United States, received a lot of attention from a substantial price increase on the AMEX over the last few months. WithRead More...
TransEnterix, Inc. , a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally invasive surgery, will showcase the Senhance™ Surgical System at the 16th World Congress of Endoscopic Surgery which is part of the 2018 Annual Meeting of the Society of American Gastrointestinal and Endoscopic Surgeons .
If scalpel-wielding robots no longer frighten you, here are three stocks you might want to buy now, and one more to keep your eyes on.
Management at the robotic surgery company has laid out its game plan for the year ahead. Here are the must-know details.
The Morrisville, North Carolina-based company said it had a loss of 40 cents per share. The maker of surgical robots and medical instruments posted revenue of $3.4 million in the period. For the year, ...
Transenterix Inc (NYSEAMERICAN:TRXC) announced its operating and financial results for the fourth quarter and full year 2017. During the quarter ended December 31, 2017, the Company sold two Senhance Systems, including its first in the U.S.
TransEnterix, Inc. , a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally invasive surgery, today announced its operating and financial results for the fourth quarter and full year 2017.
NEW YORK, NY / ACCESSWIRE / March 6, 2018 / TransEnterix, Inc. (NYSE American: TRXC ) will be discussing their earnings results in their Q4 Earnings Call to be held on March 6, 2018 at 4:30 PM Eastern ...
On Tuesday, TransEnterix, Inc. Common Stock (NYSE: TRXC ) will release its latest earnings report. Check out Benzinga's report to understand the earnings implications. Earnings and Revenue Based on management's ...
NEW YORK, Feb. 20, 2018-- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Stag ...
TransEnterix, Inc. announced today that it plans to release fourth quarter and fiscal year 2017 financial and operating results after the market closes on Tuesday, March 6, 2018.
Stock Monitor: Mettler-Toledo Intl. Post Earnings Reporting LONDON, UK / ACCESSWIRE / February 16, 2018 / Active-Investors.com has just released a free research report on TransEnterix, Inc. (NYSE: TRXC ...
TransEnterix, Inc. , a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally invasive surgery, today announced the Company has filed a FDA 510 submission to expand the indication for use of its Senhance™ Surgical System, and provided an update about commercial results thus far for the quarter ending March 31, 2018.
TransEnterix, Inc. announced today that Todd M. Pope, President and Chief Executive Officer will present at the RBC Capital Markets 2018 Global Healthcare Conference at The Lotte New York Palace Hotel in New York, New York.
TransEnterix, Inc. announced today that Todd M. Pope, President and Chief Executive Officer, and Joseph P. Slattery, Executive Vice President and Chief Financial Officer, will present at the LEERINK Partners 7th Annual Global Healthcare Conference at The Lotte New York Palace Hotel in New York, New York.
TransEnterix, Inc. , a medical device company that is pioneering the use of robotics to improve minimally invasive surgery, today provided a year-end corporate update.